GSK plc
GSK
$46.63
-$0.47-1.00%
NYSE
| 09/30/2025 | 06/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 8.03% | 12.70% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 8.03% | 12.70% | |||
| Cost of Revenue | 4.45% | 19.02% | |||
| Gross Profit | 9.36% | 10.52% | |||
| SG&A Expenses | 4.12% | 7.76% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | 14.65% | -44.95% | |||
| Total Operating Expenses | 4.78% | 13.14% | |||
| Operating Income | 15.44% | 11.70% | |||
| Income Before Tax | 31.38% | -5.06% | |||
| Income Tax Expenses | 30.68% | -23.93% | |||
| Earnings from Continuing Operations | 31.48% | -1.48% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | 34.86% | -45.48% | |||
| Net Income | 40.81% | -5.76% | |||
| EBIT | 15.44% | 11.70% | |||
| EBITDA | -1.05% | 21.58% | |||
| EPS Basic | 41.84% | -5.18% | |||
| Normalized Basic EPS | 26.00% | 6.73% | |||
| EPS Diluted | 41.20% | -5.27% | |||
| Normalized Diluted EPS | 25.36% | 6.76% | |||
| Average Basic Shares Outstanding | -0.71% | -0.61% | |||
| Average Diluted Shares Outstanding | -0.19% | -0.65% | |||
| Dividend Per Share | 0.94% | 6.05% | |||
| Payout Ratio | -0.29% | 0.21% | |||